Prot#7389-G000-309: A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma.

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/27/12 → 1/27/18

Funding

  • PPD Development (7389-G000-309)
  • Eisai, Inc. (7389-G000-309)